Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Isoniazid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 18Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J&J's tuberculosis Sirturo lands full US, EU approvals
    J&J's tuberculosis Sirturo lands full US, EU approvals

    08 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jjs-tuberculosis-med-sirturo-lands-full-us-european-approvals-after-more-decade

    FIERCE PHARMA
    08 Jul 2024
    Share Share
    FDA endorses new regimen for deadly drug-resistant tuberculosis rampant
    FDA endorses new regimen for deadly drug-resistant tuberculosis rampant

    15 Aug 2019

    // Natalie Grover ENDPTS

    https://endpts.com/fda-endorses-new-regimen-for-deadly-drug-resistant-tuberculosis-rampant-in-developing-world/

    Natalie Grover ENDPTS
    15 Aug 2019
    Share Share
    FDA advisory panel recommends approval of TB Alliance's tuberculosis treatment
    FDA advisory panel recommends approval of TB Alliance's tuberculosis treatment

    08 Jun 2019

    // REUTERS

    https://www.reuters.com/article/us-tb-alliance-fda/fda-advisory-panel-recommends-approval-of-tb-alliances-tuberculosis-treatment-idUSKCN1T72QP

    REUTERS
    08 Jun 2019
    Share Share
    WHO announces landmark changes in MDR-TB treatment regimens
    WHO announces landmark changes in MDR-TB treatment regimens

    20 Aug 2018

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/who-announces-important-changes-to-multi-drug-resistant-tb-treatment/articleshow/65444597.cms

    ECONOMIC TIMES
    20 Aug 2018
    Share Share
    New tuberculosis drug could help eradicate global killer
    New tuberculosis drug could help eradicate global killer

    02 Aug 2018

    // Joy Persaud PHARMAPHORUM

    https://pharmaphorum.com/news/new-tuberculosis-drug-could-help-eradicate-global-killer/

    Joy Persaud PHARMAPHORUM
    02 Aug 2018
    Share Share
    Cipla, Unitaid join hands to reduce HIV drug price
    Cipla, Unitaid join hands to reduce HIV drug price

    11 Jun 2018

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/28/11065/cipla-unitaid-join-hands-to-reduce-hiv-drug-price.html

    BIOSPECTRUM
    11 Jun 2018
    Share Share